174 related articles for article (PubMed ID: 2093020)
21. The effects of omeprazole and ranitidine on 24-hour pH in the distal oesophagus of patients with reflux oesophagitis.
Klinkenberg-Knol EC; Festen HP; Meuwissen SG
Aliment Pharmacol Ther; 1988 Jun; 2(3):221-7. PubMed ID: 2979246
[TBL] [Abstract][Full Text] [Related]
22. Evaluation of omeprazole in reflux oesophagitis.
Dent J; Hetzel DJ; MacKinnon MA; Reed WD; Narielvala FM
Scand J Gastroenterol Suppl; 1989; 166():76-82; discussion 94. PubMed ID: 2690334
[TBL] [Abstract][Full Text] [Related]
23. Daily omeprazole surpasses intermittent dosing in preventing relapse of oesophagitis: a US multi-centre double-blind study.
Sontag SJ; Robinson M; Roufail W; Hirschowitz BI; Sabesin SM; Wu WC; Behar J; Peterson WL; Kranz KR; Tarnawski A; Dayal Y; Berman R; Simon TJ
Aliment Pharmacol Ther; 1997 Apr; 11(2):373-80. PubMed ID: 9146778
[TBL] [Abstract][Full Text] [Related]
24. High doses of ranitidine in patients with reflux oesophagitis.
Jansen JB; Lamers CB
Scand J Gastroenterol Suppl; 1990; 178():42-6. PubMed ID: 2277968
[TBL] [Abstract][Full Text] [Related]
25. Australian clinical trials of omeprazole in the management of reflux oesophagitis.
Dent J
Digestion; 1990; 47 Suppl 1():69-71. PubMed ID: 2093019
[TBL] [Abstract][Full Text] [Related]
26. [Comparison of the cost-efficacy ratio of omeprazole and ranitidine in the treatment of reflux esophagitis].
Bergmann JF; Hamelin B; Barbier JP
Gastroenterol Clin Biol; 1995 May; 19(5):482-6. PubMed ID: 7589999
[TBL] [Abstract][Full Text] [Related]
27. Maintenance therapy for erosive esophagitis in children after healing by omeprazole: is it advisable?
Boccia G; Manguso F; Miele E; Buonavolontà R; Staiano A
Am J Gastroenterol; 2007 Jun; 102(6):1291-7. PubMed ID: 17319927
[TBL] [Abstract][Full Text] [Related]
28. Omeprazole in the treatment of patients with complicated gastro-oesophageal reflux disease.
Jaspersen D; Schwacha H; Schorr W; Brennenstuhl M; Raschka C; Hammar CH
J Gastroenterol Hepatol; 1996 Oct; 11(10):900-2. PubMed ID: 8912123
[TBL] [Abstract][Full Text] [Related]
29. A comparison of lansoprazole and ranitidine in the treatment of erosive oesophagitis. Multicentre Investigational Group.
Robinson M; Sahba B; Avner D; Jhala N; Greski-Rose PA; Jennings DE
Aliment Pharmacol Ther; 1995 Feb; 9(1):25-31. PubMed ID: 7766740
[TBL] [Abstract][Full Text] [Related]
30. Omeprazole is superior to ranitidine plus metoclopramide in the short-term treatment of erosive oesophagitis.
Robinson M; Decktor DL; Maton PN; Sabesin S; Roufail W; Kogut D; Roberts W; McCullough A; Pardoll P; Saco L
Aliment Pharmacol Ther; 1993 Feb; 7(1):67-73. PubMed ID: 8439639
[TBL] [Abstract][Full Text] [Related]
31. [Omeprazole (20 mg daily) compared to ranitidine (150 mg twice daily) in the treatment of esophagitis caused by reflux. Results of a double-blind randomized multicenter trial in France and Belgium].
Zeitoun P; Rampal P; Barbier P; Isal JP; Eriksson S; Carlsson R
Gastroenterol Clin Biol; 1989 May; 13(5):457-62. PubMed ID: 2666237
[TBL] [Abstract][Full Text] [Related]
32. Omeprazole and H2-receptor antagonists in the acute treatment of duodenal ulcer, gastric ulcer and reflux oesophagitis: a meta-analysis.
Eriksson S; Långström G; Rikner L; Carlsson R; Naesdal J
Eur J Gastroenterol Hepatol; 1995 May; 7(5):467-75. PubMed ID: 7614110
[TBL] [Abstract][Full Text] [Related]
33. Effect of omeprazole and high doses of ranitidine on gastric acidity and gastroesophageal reflux in patients with moderate-severe esophagitis.
Fiorucci S; Santucci L; Morelli A
Am J Gastroenterol; 1990 Nov; 85(11):1458-62. PubMed ID: 2239873
[TBL] [Abstract][Full Text] [Related]
34. [Prognostic factors influencing healing of reflux esophagitis. A controlled trial of omeprazole versus ranitidine. Study group Omega].
Barbier JP; Haccoun P; Bergmann JF; Arnould B; Hamelin B
Ann Gastroenterol Hepatol (Paris); 1993; 29(4):213-8. PubMed ID: 8239492
[TBL] [Abstract][Full Text] [Related]
35. Prognostic factors influencing relapse of oesophagitis during maintenance therapy with antisecretory drugs: a meta-analysis of long-term omeprazole trials.
Carlsson R; Galmiche JP; Dent J; Lundell L; Frison L
Aliment Pharmacol Ther; 1997 Jun; 11(3):473-82. PubMed ID: 9218069
[TBL] [Abstract][Full Text] [Related]
36. Lansoprazole heals erosive reflux esophagitis resistant to histamine H2-receptor antagonist therapy.
Sontag SJ; Kogut DG; Fleischmann R; Campbell DR; Richter J; Robinson M; McFarland M; Sabesin S; Lehman GA; Castell D
Am J Gastroenterol; 1997 Mar; 92(3):429-37. PubMed ID: 9068463
[TBL] [Abstract][Full Text] [Related]
37. Omeprazole versus high-dose ranitidine in mild gastroesophageal reflux disease: short- and long-term treatment. The Dutch Reflux Study Group.
Festen HP; Schenk E; Tan G; Snel P; Nelis F
Am J Gastroenterol; 1999 Apr; 94(4):931-6. PubMed ID: 10201459
[TBL] [Abstract][Full Text] [Related]
38. Efficacy of omeprazole in lower grades of gastro-oesophageal reflux disease.
Havelund T; Laursen LS; Lauritsen K
Scand J Gastroenterol Suppl; 1994; 201():69-73. PubMed ID: 8047827
[TBL] [Abstract][Full Text] [Related]
39. Omeprazole: a pharmacoeconomic evaluation of its use in duodenal ulcer and reflux oesophagitis.
Barradell LB; McTavish D
Pharmacoeconomics; 1993 Jun; 3(6):482-510. PubMed ID: 10146883
[TBL] [Abstract][Full Text] [Related]
40. Omeprazole or ranitidine plus metoclopramide for patients with severe erosive oesophagitis. A cost-effectiveness analysis.
Bloom BS; Hillman AL; LaMont B; Liss C; Schwartz JS; Stever GJ
Pharmacoeconomics; 1995 Oct; 8(4):343-9. PubMed ID: 10155675
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
